rs16991656
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 6P and 4B. PM1PM2PP3_ModerateBS2
The NM_172201.2(KCNE2):c.197C>T(p.Ala66Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000342 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_172201.2 missense
Scores
Clinical Significance
Conservation
Publications
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- long QT syndrome 6Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- long QT syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNE2 | NM_172201.2 | c.197C>T | p.Ala66Val | missense_variant | Exon 2 of 2 | ENST00000290310.4 | NP_751951.1 | |
| LOC105372791 | NR_188571.1 | n.612G>A | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||
| LOC105372791 | NR_188572.1 | n.612G>A | non_coding_transcript_exon_variant | Exon 2 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNE2 | ENST00000290310.4 | c.197C>T | p.Ala66Val | missense_variant | Exon 2 of 2 | 1 | NM_172201.2 | ENSP00000290310.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
This variant has been reported in the following publications (PMID:14661677). -
The KCNE2 c.197C>T; p.Ala66Val variant (rs16991656) is reported in the literature in at least one individual affected with long QT syndrome (Ackerman 2003). This variant is reported in ClinVar (Variation ID: 67613), but is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The alanine at codon 66 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. However, given the lack of clinical and functional data, the significance of the p.Ala66Val variant is uncertain at this time. References: Ackerman MJ et al. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003 Dec;78(12):1479-87. -
Long QT syndrome 6 Uncertain:1
This variant has not been reported in the literature in individuals affected with KCNE2-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 66 of the KCNE2 protein (p.Ala66Val). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 67613). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at